Patent

Coegin Pharma har en solid patentportfölj med 21 patentfamiljer inkluderande substanspatent, användarpatent, kombinationspatent och formuleringspatent. Patentfamiljerna i tabellen nedan har lämnats in i USA, Europa, Kanada, Japan, Australien och även i andra områden som Kina, Hongkong, Korea, Indien, Israel, Nya Zeeland och Norge.

Utvalda patentfamiljer

Novel compositions and uses thereof

PCT/GB2012/051955

Peptides for treatment of diabetes

PCT/EP2018/061547

Peptides fragments for treatment of diabetes

PCT/EP2019/080563

Topical formulation of FOL005

PCT/EP2020/061453

Peptides for use in skin and hair pigmentation

PCT/EP2021/080032

AVX001/AVX002 type compounds – treatment of psoriasis

 

PCT/GB03/000364

AVX001 type ketones for the treatment of glomerulonephritis

PCT/EP2010/003384

Oxothiazole compounds and their use for the treatment of certain

chronic inflammatory conditions

PCT/2010/064687

Oxothiazole compounds and their use in the treatment of chronic

inflammatory disorders and proliferative disorders such as cancer

PCT/EP2014/051655

Oxothiazole compounds and their use for the treatment of chronic inflammatory disorders and proliferative disorders such as cancer

PCT/EP2015/067836

AVX001 type ketones for the treatment of skin cancer

PCT/EP2015/061534

AVX001 and AVX002 in combination with BEZ235

PCT/EP2017/056022

AVX235 and AVX420 in combination with BEZ235

PCT/EP2017/056016

Formulation comprising AVX001 type ketones and silicone

PCT/EP2017/073951

Oxothiazole compounds in combination with a secosteroid

PCT/EP2017/078169

Oxothiazole compounds in combination with a corticosteroid

PCT/EP2017/078162

AVX001 type ketones for the treatment of fibrotic diseases

PCT/EP2018/066028

Oxothiazole compounds for the treatment of fibrotic diseases

PCT/EP2019/060544

AVX001/AVX002 type compounds for use in the prevention of metastasis in cancer

PCT/EP2020/071168

Novel compositions and uses thereof

PCT/GB2012/051955

Peptides for treatment of diabetes

PCT/EP2018/061547